<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01251549</url>
  </required_header>
  <id_info>
    <org_study_id>RW003 ver. 4</org_study_id>
    <nct_id>NCT01251549</nct_id>
  </id_info>
  <brief_title>Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)</brief_title>
  <official_title>Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReWalk Robotics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ReWalk Robotics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ReWalk suit developed by Argo Medical Technologies is designed to enable people with lower
      limb disabilities to carry out routine ambulatory functions (stand, walk etc.); it can be
      used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple
      sclerosis, cerebral palsy and other pathologies that produce severe walking impairments.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of use</measure>
    <time_frame>3 months</time_frame>
    <description>Number of participants with related adverse events as a Measure of Safety and Tolerability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy</measure>
    <time_frame>3 months</time_frame>
    <description>Continuously walking for 6 minutes after 18 sessions training with the ReWalk - exoskeleton suit performed at weekly intervals</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Paraplegia</condition>
  <condition>Spinal Cord Injuries (SCI)</condition>
  <arm_group>
    <arm_group_label>Experimental: A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A group of paraplegics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReWalk - a motorized exoskeleton suit</intervention_name>
    <description>The subject will wear the ReWalk suit and have training sessions for walking with the device</description>
    <arm_group_label>Experimental: A</arm_group_label>
    <other_name>Exoskeleton suit</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complete cervical (C7-8) or thoracic (T1-T12) spinal cord injury according to American
             Spinal Injury Association (ASIA) guidelines

          -  Male and non-pregnant non-lactating female Age 18-55

          -  At least 6 months after injury

          -  Regular use of RGO (Reciprocating Gait Orthosis) or KAFO's (Knee Ankle Foot Orthoses)
             or able to stand using a standing device (e.g., 'Easy stand')

          -  Patients must be capable of providing informed consent

          -  Height of 160 to 190 cm

          -  Weight of &lt;100 kg

        Exclusion Criteria:

          -  History of severe neurological injuries other than SCI (Spinal Cord Injuries)(MS
             (Multiple Sclerosis), CP (Cerebral Palsy), ALS (Amyotrophic Lateral Sclerosis) , TBI
             (Traumatic Brain Injury) etc)

          -  Severe concurrent medical diseases: infections, circulatory, heart or lung, pressure
             sores

          -  Severe spasticity (Ashworth 4) or uncontrolled clonus

          -  Unstable spine or unhealed limbs or pelvic fractures

          -  Heterotopic ossification

          -  Significant contractures

          -  Psychiatric or cognitive situations that may interfere with the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alberto Esquenazi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein Medical Center, Moss Rehabilitation Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Albert Einstein Medical Center, Moss Rehabilitation Center</name>
      <address>
        <city>Elkins Park</city>
        <state>Pennsylvania</state>
        <zip>19027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Valduce di Como, Centro Villa Beretta Italy</name>
      <address>
        <city>Como</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2010</study_first_submitted>
  <study_first_submitted_qc>November 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2010</study_first_posted>
  <last_update_submitted>October 4, 2016</last_update_submitted>
  <last_update_submitted_qc>October 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ReWalk</keyword>
  <keyword>Paraplegia</keyword>
  <keyword>Spinal Cord Injuries (SCI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

